Results
88
Companies with strong growth potential, backed by optimistic outlooks both from analysts and management.
88 companies
Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | Industry | ||
---|---|---|---|---|---|---|---|---|---|---|---|
KEBNI B | SEK 1.42 | -7.4% | 1.6% | SEK 384.5m | SEK 2.20 | PS4.2x | E90.4% | n/a | Tech | ||
CALTX | SEK 206.20 | 0% | 115.8% | SEK 11.1b | SEK 221.25 | PS8.5x | E52.9% | n/a | Pharmaceuticals & Biotech | ||
YUBICO | SEK 247.00 | -7.8% | 147.0% | SEK 21.3b | SEK 267.50 | PE128.4x | E43.8% | n/a | Software | ||
MAGLE | SEK 41.00 | -8.9% | 18.5% | SEK 442.8m | SEK 50.00 | PE57.5x | E72.2% | n/a | Pharmaceuticals & Biotech | ||
CTT | SEK 265.00 | -2.2% | 22.1% | SEK 3.3b | n/a | PE32.6x | E24.8% | 2.0% | Capital Goods | ||
YIELD | SEK 2.38 | -0.8% | -66.5% | SEK 136.3m | SEK 9.00 | PB1.6x | E103.4% | n/a | Diversified Financials | ||
EDYOU | SEK 1.30 | 4.7% | 1.0% | SEK 48.4m | n/a | PS1.5x | E63.1% | n/a | Media | ||
BIOA B | SEK 159.00 | 1.1% | -46.2% | SEK 14.0b | SEK 326.40 | PS55.7x | E104.2% | 0% | Pharmaceuticals & Biotech | ||
BIOVIC B | SEK 2.90 | 1.2% | -69.8% | SEK 243.3m | SEK 7.90 | PS33.4x | E73.8% | n/a | Pharmaceuticals & Biotech | ||
INCOAX | SEK 2.26 | -1.3% | -25.9% | SEK 244.4m | SEK 3.65 | PS2.5x | E104.9% | n/a | Tech | ||
CRAD B | SEK 42.40 | -3.6% | 41.8% | SEK 1.4b | SEK 57.00 | PE26.7x | E33.9% | n/a | Healthcare | ||
ORGC | SEK 3.12 | -6.3% | -32.6% | SEK 306.1m | SEK 3.00 | PS2.2x | E109.0% | n/a | Materials | ||
CTM | SEK 6.09 | -18.1% | -74.7% | SEK 460.7m | SEK 29.70 | PB0.2x | E115.4% | 0% | Media | ||
FLEXQ | SEK 10.25 | -2.4% | -63.5% | SEK 137.4m | SEK 25.00 | PS1.1x | E111.9% | n/a | Capital Goods | ||
EQT | SEK 313.40 | -5.3% | 30.0% | SEK 370.7b | SEK 360.17 | PE106.6x | E56.9% | 1.1% | Diversified Financials | ||
TRUE B | SEK 32.36 | -4.8% | -19.1% | SEK 11.2b | SEK 54.83 | PE23.4x | E21.5% | 1.2% | Software | ||
KLAR | SEK 0.30 | -12.8% | -54.5% | SEK 38.9m | SEK 1.00 | PB1.3x | E61.3% | n/a | Pharmaceuticals & Biotech | ||
MIDS | SEK 1.31 | -6.3% | -45.3% | SEK 275.1m | SEK 2.80 | PS4.3x | E89.9% | n/a | Semiconductors | ||
SENZA | SEK 7.15 | 0% | -30.2% | SEK 211.0m | SEK 16.50 | PS4.1x | E67.8% | n/a | Pharmaceuticals & Biotech | ||
4C | SEK 20.90 | 2.0% | -19.5% | SEK 734.3m | SEK 22.00 | PS2.5x | E108.0% | n/a | Software | ||
FNOX | SEK 61.86 | -6.0% | -2.2% | SEK 37.7b | SEK 73.00 | PE58.1x | E22.6% | 0.3% | Software | ||
EGTX | SEK 5.90 | -3.6% | 38.8% | SEK 1.7b | SEK 13.30 | PS27.4x | E98.6% | n/a | Pharmaceuticals & Biotech | ||
NIUTEC | SEK 6.50 | -1.5% | -41.8% | SEK 132.4m | SEK 9.50 | PB1.6x | E94.1% | n/a | Capital Goods | ||
ALELIO | SEK 0.05 | 0.6% | -91.2% | SEK 31.1m | n/a | PE-0.5x | E106.6% | n/a | Capital Goods |